Gilead Sciences, Inc.

GILD · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$9,991$6,085$5,412$5,338
Short-Term Investments$1,577$1,179$973$1,182
Receivables$4,420$4,660$4,777$4,493
Inventory$1,710$1,787$1,507$1,618
Other Curr. Assets$1,475$2,374$1,774$2,141
Total Curr. Assets$19,173$16,085$14,443$14,772
Property Plant & Equip (Net)$5,414$5,317$5,475$5,121
Goodwill$8,314$8,314$8,314$8,332
Intangibles$19,948$26,454$28,893$33,455
Long-Term Investments$0$1,163$1,245$1,309
Tax Assets$0$0$0$0
Other NC Assets$6,146$4,792$4,800$4,963
Total NC Assets$39,822$46,040$48,727$53,180
Other Assets$0$0$1$0
Total Assets$58,995$62,125$63,171$67,952
Liabilities
Payables$833$550$905$705
Short-Term Debt$1,815$1,798$2,273$1,516
Tax Payable$830$1,208$959$539
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8,526$7,724$7,101$8,850
Total Curr. Liab.$12,004$11,280$11,238$11,610
LT Debt$24,896$23,189$22,957$25,179
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$724$1,588$2,673$4,356
Other NC Liab.$2,125$3,319$5,094$5,743
Total NC Liab.$27,745$28,096$30,724$35,278
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$39,749$39,376$41,962$46,888
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings$11,497$16,304$15,687$16,324
AOCI$132$28$2$83
Other Equity$7,700$6,500$5,550$4,661
Total Equity$19,330$22,833$21,240$21,069
Supplemental Information
Minority Interest-$84-$84-$31-$5
Total Liab. & Tot. Equity$58,995$62,125$63,171$67,952
Net Debt$16,720$18,902$19,818$21,357
Gilead Sciences, Inc. (GILD) Financial Statements & Key Stats | AlphaPilot